Last reviewed · How we verify
JAB-8263
At a glance
| Generic name | JAB-8263 |
|---|---|
| Sponsor | Jacobio Pharmaceuticals Co., Ltd. |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- A First-in-Human Study of JAB-8263 in Adult Patients With Advanced Solid Tumors (PHASE1)
- A First-in-Human, JAB-8263 in Adult Patients With Advanced Tumors (PHASE1, PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |